Schering-Plough HealthCare Products, Inc. has recalled two of their MiraLAX products due to unsecured and incorrectly sealed caps which is a potential threat to public health. MiraLAX (which is Polyethylene Glycol 3350) is a treatment for constipation. The product recall is for MiraLAX Laxative Power (30-day dose, 17.9 oz.) which has a UPC (barcode) of 4110082071. The second product is MiraLAX Laxative(30 day dose, 19.9 oz.) with a UPC of 4110080770.
"MiraLAX works by naturally balancing the water in your digestive system to relieve constipation with no harsh side effects. It gently increases the frequency of bowel movements and softens the stool so it is easier to pass. MiraLAX draws water back to your colon, replacing what was lost, and allows you to have a normal, easy and complete bowel movement. As it works, it provides more comfort and less straining without uncomfortable side effects. And you can control the urge to go." says Schering-Plough HealthCare Products, Inc., the makers of the product.
"MiraLAX is safe and effective - and is available without a prescription. It is the first prescription laxative in more than 30 years to be made available over-the-counter (OTC)," the company also claims.
In November 2009, Schering-Plough Corporation merged with Merck & Co. and is among the top twenty pharmaceutical companies by sales. Schering-Plough is the manufacturer of several pharmaceutical drugs including the allergy drugs Claritin and Clarinex. The company also makes Vytorin, an anti-cholesterol drug, through its collaboration with Merck & Co. Schering Plough also owns the major foot care brand Dr. Scholl's and the skin care line Coppertone.